valsartan has been researched along with Dilatation, Pathologic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mir, TS; Mueller, GC; Stark, V; Steiner, K; Stierle, L; von Kodolitsch, Y; Weil, J | 1 |
| Xu, C; Xu, J; Zhao, L | 1 |
2 other study(ies) available for valsartan and Dilatation, Pathologic
| Article | Year |
|---|---|
Retrospective analysis of the effect of angiotensin II receptor blocker versus β-blocker on aortic root growth in paediatric patients with Marfan syndrome.
Topics: Adolescent; Adrenergic beta-1 Receptor Antagonists; Age Factors; Angiotensin II Type 1 Receptor Blockers; Aortic Diseases; Child; Child, Preschool; Dilatation, Pathologic; Female; Humans; Male; Marfan Syndrome; Metoprolol; Retrospective Studies; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2014 |
Autoantibodies against β1 receptor and AT1 receptor in type 2 diabetes patients with left ventricular dilatation.
Topics: Aged; Antihypertensive Agents; Autoantibodies; Biomarkers; Diabetes Mellitus, Type 2; Dilatation, Pathologic; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Metoprolol; Middle Aged; Predictive Value of Tests; Receptor, Angiotensin, Type 1; Receptors, Adrenergic, beta-1; Risk Factors; Sensitivity and Specificity; Tetrazoles; Valine; Valsartan | 2014 |